Press Releases
NEW YORK--(BUSINESS WIRE)-- Equitable Holdings, Inc. (the “Company”) (NYSE: EQH), the leading financial services holding company of Equitable, AllianceBernstein and Equitable Advisors, today announced that it has commenced a cash tender offer (the “Tender Offer”) to purchase the outstanding debt securities listed in the table below (collectively, the “Notes” and each a “Series” of Notes) having an aggregate purchase price (excluding accrued interest)... (continue reading...)
NEW YORK and MEXICO CITY, June 3, 2024 /PRNewswire/ -- Bloomberg SEF LLC today announced that the first electronically traded TIIE de Fondeo ("F-TIIE") swap transaction was executed on its CFTC-registered swap execution facility, BSEF. Mexico-based Banco Invex and Finamex Casa de Bolsa traded a 3-month swap on BSEF using request-for-quote (RFQ) trading protocol. The trade was cleared by CME Clearing. Mexican derivatives markets seek to replace their usage of the... (continue reading...)
SALT LAKE CITY--(BUSINESS WIRE)-- Bridge Investment Group Holdings Inc. (NYSE: BRDG) (“Bridge” or the “Company”) today announced Alison Brown will be joining the Company as President of Bridge Property Management and Deputy Chief Investment Officer for Bridge’s Workforce and Affordable Housing Strategy, effective July 1, 2024.
Brown brings over 25 years of real estate experience and a proven track record of building and supporting successful teams. She... (continue reading...)
Company plans to release topline results from “lead-in” patients (n=5) imminently
THE WOODLANDS, TX, June 03, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced it has received Ethics Committee approval of the protocol amendment for its... (continue reading...)
NEW YORK--(BUSINESS WIRE)-- Focus Financial Partners Inc., a leading partnership of fiduciary wealth management firms and related financial services firms, announced today that the NorthCoast Asset Management business line of Connectus Wealth Advisers, headquartered in Greenwich, Connecticut, has formally joined fellow Focus firm Kovitz Investment Group Partners, LLC.
NorthCoast joined Connectus in 2021 and specializes in quantitative research, a systematic... (continue reading...)
More Press Releases
View Older Stories-
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
-
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
-
DIGITIMES Asia: Nvidia's Jensen Huang discloses next-gen Ruben platform and physical AI vision at NTU keynote
-
Rigel Highlights New Data in Three Poster Presentations at the 2024 ASCO Annual Meeting
-
Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family
-
Molecular Templates, Inc. Provides Interim Update
-
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
-
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution for Unmanned Aircraft Systems
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 31 05 2024] - (CGWL)
-
Coherent Appoints Jim Anderson as Chief Executive Officer
-
Aptevo Participating in the BIO International Convention
-
CNS Pharmaceuticals Announces Reverse Stock Split
-
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental Wellbeing 2024”
-
V2X announces successful repricing and extension of Term Loan
-
Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass Spectrometer
-
Kelley Shaw Joins Alliant Employee Benefits, Will Service Diverse Southeast Client Base
-
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024
-
InnovAge PACE Recertified as a Great Place to Work
-
TÜV Rheinland's Northeast Technology & Innovation Center receive accreditation to verify equipment to be imported into Korea and other significant accreditations
-
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
-
Grace Science, LLC Selected by FDA to Participate in the START Pilot Program for GS-100 Gene Therapy for NGLY1 Deficiency and Announcement of the Successful Treatment of the 2nd Patient
-
U.S.-based Lithium Producer International Battery Metals (IBAT) Names Iris Jancik as CEO to Lead Global Commercial Expansion
-
Teako Minerals Announces Changes to the Board of Directors and Officer Roles
-
Oleg Firer Wins Judgement Against Grenada Government for Unlawful Recall
-
Argo Completes First Phase of MOU with Connective Global, Secures R&D Facility at University Putra Malaysia
-
Ready Capital to Present at Nareit’s REITweek 2024
-
MIT Sloan Management Review Research Examines Circular Business Models' Benefit to Bottom Line and Increased Sustainability Measures
-
PureCycle Provides Update on Ironton Purification Facility
-
Modular Medical Announces Addition to the Russell Microcap(R) Index
-
Gryphon Digital Mining set to join Russell Microcap(R) Index
-
Ensysce Biosciences to Participate in the EPHMRA 2024 Annual Meeting
-
Element 29 Announces New Board Nominees
-
Early Warning Report Issued Pursuant to National Instrument 62-103 - Acquisition of Securities of Spanish Mountain Gold Ltd.
-
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
-
Aldo Mazzaferro Joins Headwall Partners
-
Millennial Potash Announces Private Placement For Proceeds Of Up To $2,000,000
-
Atlas Lithium to Co-host the Inaugural Brazil Lithium Summit
-
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survi
-
Gear Energy Ltd. Confirms Monthly Dividend for June of $0.005 per Share
-
Neurocrine Biosciences Presented CAHtalyst™ Phase 3 Pediatric and Adult Studies, CAHtalog™ Registry and Disease- and Glucocorticoid-Related Comorbidities Data in CAH at ENDO 2024
-
AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
-
Texas Must Close Primary Elections
-
Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies
-
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual Meeti
-
Promising Phase 2 Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have a 100% Lifetime Risk of Colorectal Cancer
-
GOAI and Domain Development Corp Announce Strategic Partnership to Drive Revenue Growth
-
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
-
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
-
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
-
CHATHAM ASSET MANAGEMENT SENDS LETTER TO SINCLAIR REGARDING REFINANCING EFFORTS